These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 25622104)

  • 1. An update on the LIM and SH3 domain protein 1 (LASP1): a versatile structural, signaling, and biomarker protein.
    Orth MF; Cazes A; Butt E; Grunewald TG
    Oncotarget; 2015 Jan; 6(1):26-42. PubMed ID: 25622104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LASP1 in Tumor and Tumor Microenvironment.
    Hu Z; Wang X; Cui Y; Li C; Wang S
    Curr Mol Med; 2017; 17(8):541-548. PubMed ID: 29473505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COPS5 and LASP1 synergistically interact to downregulate 14-3-3σ expression and promote colorectal cancer progression via activating PI3K/AKT pathway.
    Zhou R; Shao Z; Liu J; Zhan W; Gao Q; Pan Z; Wu L; Xu L; Ding Y; Zhao L
    Int J Cancer; 2018 May; 142(9):1853-1864. PubMed ID: 29226323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Expression of LIM and SH3 protein 1 in renal clear cell carcinoma and its effects on invasion and migration of renal clear cell carcinoma 786-O cells].
    Jin B; Gao L; Li W; Chen JC; Wen RM; Wang JQ
    Zhonghua Zhong Liu Za Zhi; 2017 Mar; 39(3):166-171. PubMed ID: 28316213
    [No Abstract]   [Full Text] [Related]  

  • 5. LIM and SH3 protein 1 induces TGFβ-mediated epithelial-mesenchymal transition in human colorectal cancer by regulating S100A4 expression.
    Wang H; Shi J; Luo Y; Liao Q; Niu Y; Zhang F; Shao Z; Ding Y; Zhao L
    Clin Cancer Res; 2014 Nov; 20(22):5835-47. PubMed ID: 25252758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of tumor suppressor mir-203 mediates overexpression of LIM and SH3 Protein 1 (LASP1) in high-risk prostate cancer thereby increasing cell proliferation and migration.
    Hailer A; Grunewald TG; Orth M; Reiss C; Kneitz B; Spahn M; Butt E
    Oncotarget; 2014 Jun; 5(12):4144-4153. PubMed ID: 24980827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LIM and SH3 protein 1 induces glioma growth and invasion through PI3K/AKT signaling and epithelial-mesenchymal transition.
    Zhong C; Li X; Tao B; Peng L; Peng T; Yang X; Xia X; Chen L
    Biomed Pharmacother; 2019 Aug; 116():109013. PubMed ID: 31146105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LASP1-S100A11 axis promotes colorectal cancer aggressiveness by modulating TGFβ/Smad signaling.
    Niu Y; Shao Z; Wang H; Yang J; Zhang F; Luo Y; Xu L; Ding Y; Zhao L
    Sci Rep; 2016 May; 6():26112. PubMed ID: 27181092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of matrix metalloproteinases (MMPs) expression and secretion in MDA-MB-231 breast cancer cells by LIM and SH3 protein 1 (LASP1).
    Endres M; Kneitz S; Orth MF; Perera RK; Zernecke A; Butt E
    Oncotarget; 2016 Sep; 7(39):64244-64259. PubMed ID: 27588391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of LASP1 is associated with proliferation, migration and invasion in esophageal squamous cell carcinoma.
    He B; Yin B; Wang B; Chen C; Xia Z; Tang J; Yuan Y; Feng X; Yin N
    Oncol Rep; 2013 Mar; 29(3):1115-23. PubMed ID: 23254782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LASP1, a Newly Identified Melanocytic Protein with a Possible Role in Melanin Release, but Not in Melanoma Progression.
    Vaman V S A; Poppe H; Houben R; Grunewald TG; Goebeler M; Butt E
    PLoS One; 2015; 10(6):e0129219. PubMed ID: 26061439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LASP1 in Cellular Signaling and Gene Expression: More than Just a Cytoskeletal Regulator.
    Butt E; Howard CM; Raman D
    Cells; 2022 Nov; 11(23):. PubMed ID: 36497077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endometrial stromal cell proteomic analysis reveals LIM and SH3 protein 1 (LASP1) plays important roles in the progression of adenomyosis.
    Liu F; Li Z; Guo J; Fang S; Zhou J; Cao B; Liu J; Yi Y; Yuan X; Xu X; Huang O; Wang L; Zou Y
    Mol Hum Reprod; 2021 Feb; 27(3):. PubMed ID: 33543750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LASP1 is a HIF1α target gene critical for metastasis of pancreatic cancer.
    Zhao T; Ren H; Li J; Chen J; Zhang H; Xin W; Sun Y; Sun L; Yang Y; Sun J; Wang X; Gao S; Huang C; Zhang H; Yang S; Hao J
    Cancer Res; 2015 Jan; 75(1):111-9. PubMed ID: 25385028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paving the path for invasion: The polyedric role of LASP1 in cancer.
    Ruggieri V; Agriesti F; Tataranni T; Perris R; Mangieri D
    Tumour Biol; 2017 Jun; 39(6):1010428317705757. PubMed ID: 28621232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-133a represses tumour growth and metastasis in colorectal cancer by targeting LIM and SH3 protein 1 and inhibiting the MAPK pathway.
    Wang H; An H; Wang B; Liao Q; Li W; Jin X; Cui S; Zhang Y; Ding Y; Zhao L
    Eur J Cancer; 2013 Dec; 49(18):3924-35. PubMed ID: 23968734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LIM and SH3 protein 1 regulates cell growth and chemosensitivity of human glioblastoma via the PI3K/AKT pathway.
    Zhong C; Chen Y; Tao B; Peng L; Peng T; Yang X; Xia X; Chen L
    BMC Cancer; 2018 Jul; 18(1):722. PubMed ID: 29980193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of the 14-3-3σ is essential for LASP1-mediated colorectal cancer progression via activating PI3K/AKT signaling pathway.
    Shao Z; Cai Y; Xu L; Yao X; Shi J; Zhang F; Luo Y; Zheng K; Liu J; Deng F; Li R; Zhang L; Wang H; Li M; Ding Y; Zhao L
    Sci Rep; 2016 May; 6():25631. PubMed ID: 27156963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LASP1 promotes nasopharyngeal carcinoma progression through negatively regulation of the tumor suppressor PTEN.
    Gao Q; Tang L; Wu L; Li K; Wang H; Li W; Wu J; Li M; Wang S; Zhao L
    Cell Death Dis; 2018 Mar; 9(3):393. PubMed ID: 29531214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional role of LASP1 in cell viability and its regulation by microRNAs in bladder cancer.
    Chiyomaru T; Enokida H; Kawakami K; Tatarano S; Uchida Y; Kawahara K; Nishiyama K; Seki N; Nakagawa M
    Urol Oncol; 2012; 30(4):434-43. PubMed ID: 20843712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.